Objective: The effect of gender on outcomes after lower extremity revascularization is controversial. The aim of our systemic review and meta-analysis was to evaluate the gender-related outcomes after peripheral vascular interventions.
An estimated 20% to 30% of patients with claudication have the potential to develop worsening claudication or critical limb ischemia (CLI), with many ultimately undergoing revascularization. 1 Advanced age, significant comorbidities (diabetes, renal failure), and advanced ischemia, such as gangrene, confer a higher risk of poor outcomes after revascularization for peripheral arterial disease (PAD). 2 The effect of gender on outcomes remains uncertain. Women have a higher prevalence of asymptomatic PAD and a higher proportion of CLI than men. 3, 4 Women have also been found to have a faster functional decline and a worse walking ability after supervised exercise. 5, 6 Gender-related differences in outcomes after intervention for carotid artery disease and coronary artery disease have been widely investigated, and relevant evidence-based gender-specific intervention guidelines have been published. 7, 8 However, few guidelines in PAD have made treatment recommendations according to gender. The results of the literature are inconsistent. On the one hand, a large number of studies have demonstrated significant gender-related differences in outcomes after peripheral vascular interventions. [9] [10] [11] [12] [13] [14] [15] On the other hand, studies have reported similar clinical outcomes between women and men.
meta-analysis was to investigate the gender-related short-term and long-term clinical outcomes after peripheral vascular intervention by pooling studies that reported differences between men and women after lower limb revascularization.
METHODS
We performed this systemic review and meta-analysis according to the Cochrane Handbook for Systematic Reviews of Interventions (version 5.1.0) 21 and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. 22 The registration number at the International Prospective Register of Systematic Reviews (PROSPERO) was CRD42015027573.
Data sources and search strategy. We conducted our electronic literature search in the following databases: Ovid MEDLINE 1946 to June 2015, Ovid Embase 1974 to June 2015, Cochrane Database (up to June 2015), and Scopus (up to June 2015). We also manually searched the reference lists of relevant studies retrieved from the electronic search for more citations. We repeated our literature search before the final analysis on December 5, 2015. The main keywords contained the following aspects:
1. Type of exposure: "gender", "sex", "women", "men", "female", "male" 2. Interested disease: "peripheral arterial disease", "claudication", "critical limb ischemia"
A detailed search strategy is provided in the Appendix (online only).
Selection criteria. Two authors (J.W. and Y.H.) independently performed the study selection by using standard inclusion and exclusion criteria. Disagreements were resolved by discussion with a third author (L.D.). The inclusion criteria consisted of the following items: Quality assessment. Two authors (J.W. and Y.H.) independently evaluated the quality of each included study. Discrepancy was resolved by consensus meeting or by consulting with a third reviewer (J.Z.). We used the Newcastle-Ottawa Scale (NOS) for cohort studies 23 to assess the quality of the included nonrandomized studies. This NOS uses a star system ranging from 0 to 9 stars, which covers three perspectives: the selection of cohorts, the comparability of groups, and the adequacy of outcome assessment and reporting. A study that received a score of $7 was considered to be of highquality.
Statistical analysis. We summarized the effects across included studies according to methods outlined in the Cochrane Handbook for Systematic Reviews of Interventions (version 5.1.0). For time-to-event data, we applied generic inverse-variance method to analyze hazard ratios (HRs) and standard errors obtained from the results of Cox proportional hazards regression models. If they were not available in the full-text, we used the methods of Tierney et al 24 to estimate the HRs and standard errors.
For dichotomous data, we entered totals and numbers of events in each gender group and calculated the odds ratio (OR) with 95% confidence intervals (CIs) with the Mantel-Haenszel method. 25 We used the c 2 heterogeneity test and I 2 statistic to assess the overall heterogeneity across studies. Given the observational nature of the studies included, we used a random-effects model when pooling the results. We assessed publication bias by visually inspecting the funnel plots for any asymmetry and also tested whether any significant publication bias was present by using the modified Egger test, as described by Peters et al, 26 for use with dichotomous data for mortality and graft thrombosis. All tests were two-sided, and a P value of <.05 was considered significant, except for a P < .10 in the c 2 heterogeneity test. We used Review Manager 5.1 software (The Nordic Cochrane Centre, København, Denmark) for statistical analysis.
Sensitivity analysis. To account for differences in baseline risk factors, we performed sensitivity analyses by excluding studies that did not match risk factors between the two gender groups. We also performed another sensitivity analysis by only including highquality studies (NOS $7). We conducted subgroup analyses by pooling the results of studies that reported outcomes after endovascular procedures and open procedures separately. For the studies reporting long-term outcomes, we also did subgroup analyses of the studies reporting the outcomes after revascularization for CLI. We accounted for the technical advances made in endovascular therapies by conducted a separate sensitivity analysis that restricted the pooling of studies reporting endovascular therapy to those that were published from 2010 to 2015 for 30-day mortality, early graft thrombosis, and primary patency.
RESULTS

Study selection and characteristics
After duplicates were removed, we retrieved 2426 records from the electronic search and identified three additional articles through searching the references of the included studies. After study screening by two authors, we included 40 studies from 39 articles in the quantitative analysis.
9-20,27-53 Lo et al 14 included two different patient populations, and these were treated as separate studies for the purposes of data pooling. The detailed selection process is shown in the PRISMA diagram (Fig 1) . The main characteristics of included studies are summarized in the Early graft thrombosis and embolization. Graft thrombosis was described in 15 studies and embolization in seven. We observed significantly higher risks of early graft thrombosis in women with nonsignificant heterogeneity (OR, 1.56; 95% CI, 1.28-1.90; P < .0001; I 2 ¼ 3%; Fig 4) Cardiac events. Cardiac events, including myocardial infarction and arrhythmia, were documented in 16 studies. Our meta-analysis indicated a significantly increased risk of cardiac events #30 days of the procedure in women without heterogeneity across the studies (OR, 1.21; 95% CI, 1.16-1.26; P < .0001; I 2 ¼ 0%; Supplementary Fig 1, online only) . A similar result was Pulmonary complications. Nine studies described the incidence of postoperative pulmonary complications. Pooling the results showed women were at significantly increased risk with nonsignificant heterogeneity (OR, 1.07; 95% CI, 1.03-1.12; P ¼ .0006; I 2 ¼ 5%).
Renal complications. Renal complications were reported in eight studies. We did not find a significant difference between women and men (OR, 1.03; 95% CI, 0.76-1.39; P ¼ .86; I 2 ¼ 0%). Long-term outcomes after peripheral vascular intervention Survival. Kaplan-Meier curve data for cumulative survival were presented in 17 studies. We did not observe a significant difference between women and men in long-term survival (HR, 1.10; 95% CI, 0.97-1.24; P ¼ .12; I 2 ¼ 39%; Fig 6) Primary patency. Primary patency was described in 22 studies. We did not find a significant difference between women and men, although there was a trend of towards better patency in men (HR, 1.14; 95% CI, 1.00-1.30; P ¼ .06; I 2 ¼ 59%; Fig 7) . (Fig 9) and a negative modified Egger test (P ¼ .15) suggest no significant publication bias, whereas the funnel plot for graft thrombosis (Fig 10) suggests that there were fewer smaller studies with negative results (see absent studies from lower left hand corner). This in conjunction with a positive modified Egger test (P ¼ .01) indicates that publication bias is likely present for studies reporting graft thrombosis.
DISCUSSION
Our aim in this systemic review and meta-analysis was to evaluate the effect of gender on short-term and long-term outcomes after intervention for PAD. Except for 30-day reinterventions, women had inferior shortterm outcomes compared with men, and had higher rates of 30-day mortality, 30-day amputations, early graft thrombosis, embolization, vascular access site complications, cardiac events, strokes, and pulmonary complications after revascularization. When endovascular and open procedures were examined separately, women retained their increased risks of postoperative mortality and complications. Long-term outcomes between the sexes, however, did not differ, and rates of cumulative survival, graft patency, and limb salvage were similar.
Isolating the potential effect of gender on outcomes after revascularization is difficult because various factors that are associated with outcomes after intervention, such as stages of disease, comorbidities, and location of atherosclerosis (iliac vs infrainguinal), can confound the analysis. The variable way in which studies included in this meta-analysis controlled for these confounders, in addition to variable lengths of follow-up and outcome definitions, likely contributed to the high degree of heterogeneity observed between studies. To address this heterogeneity, we performed subgroup analysis by disease status and intervention type. The only change in the results was for patients with CLI, where women had significantly worse cumulative survival but similar primary patency compared with men. Women who undergo open revascularization for CLI may represent a particularly high-risk group worthy of close follow-up. In the endovascular subgroup, women retained their association with poor short-term outcomes, which included significantly increased risks of 30-day mortality and early graft thrombosis. Notably, women experienced a nearly twofold increase in the risk of vascular access site complications after endovascular interventions. When the analysis was restricted to studies reporting on the results after open surgery, women again had inferior short-term outcomes and higher rates of perioperative mortality and complications.
The finding that women have inferior postprocedural outcomes may be related to patient selection, confounding, or actual pathophysiologic differences between men and women. One of the most consistent findings in all the studies reporting on PAD was that women tended to be older at the time of their intervention, which was not always corrected for in the included studies. Women are also less likely to have good medical optimization at the time of the procedure. The degree of underutilization of antiplatelet agents, statins, and other cardiovascular medications is greater in women compared with men. 9, 14 Women are also known to present with more advanced disease and are more likely to delay treatment. 13, 18, 54 This may translate to more extensive revascularizations with compromised run-off. Unfortunately, anatomic details were often missing from the included studies and could not be assessed. Women have also been found to have more depressive symptoms and poorer physical and mental health status scores at the initial diagnosis, suggesting they are more debilitated at the time of the intervention. 55 Even when we restricted our analysis to studies that matched men and women on preoperative risk factors for outcomes after intervention, we still identified higher postprocedure mortality and complications in women. This may still have been the result of residual confounding for the reasons mentioned above or it may be partly related to differences in biology between the sexes. Women are known to have smaller-diameter venous conduits and target vessels, which likely contributed to the higher procedural complication rates, particularly the higher rates of graft thrombosis and access site complications. 41, 56 This likely explains the increased risk of local complications seen in women, but certainly, the increased risks of systemic complications after the intervention (cardiac events and strokes) suggests that other factors also influence the higher rates of morbidity and mortality seen in women. Basic science work has found that women have a heightened oxidative status, which might result in increased endothelial oxidative stress compared with men. Moreover, women harbor a more significant proinflammatory profile of circulating biomarkers and more limited peripheral microcirculation than men. 57 The finding that women have inferior outcomes after interventions is not isolated to peripheral vascular disease. Women are known to have inferior outcomes after aortic aneurysm repair and carotid endarterectomy. 8, 58 Similar factors are likely responsible for these findings in other vascular disease beds, with women being older, and having more advanced disease, smaller vessels, and inferior medical optimization at the time of their intervention. 58 To the best of our knowledge, this is the first metaanalysis that evaluates the gender-related outcomes after interventions for PAD. One of the major strengths Funnel plot of studies reporting on 30-day mortality between men and women. CLI, Critical limb ischemia; OR, odds ratio; SE, standard error. of our study was the broad inclusion criteria and the large number of included studies, which translated to significant statistical power. In addition, most included studies were of high-quality, with a NOS $7. We also performed multiple sensitivity analyses by only including studies that matched cardiovascular risk factors or restricting the analysis to high-quality studies, both of which confirmed our main findings. Some limitations should also be considered when interpreting our results, most of which relate to the varying quality of the included studies. Most of the included studies were retrospective observational studies that were prone to selection bias and confounding. Many of the studies failed to control for the differences in baseline characteristics between men and women, in particular, age, because women tended to be older than men when the intervention occurred. Only a small number of studies matched the groups by cardiovascular medications, a strong predictor of outcomes.
Many of the outcomes displayed significant statistical heterogeneity, which our subgroup analyses only partly corrected. Clinical heterogeneity was also evident: studies reported different indications for treatment, specific interventions, patient baseline characteristics, and nonstandardized outcome definitions. The heterogeneity seemed to be greatest when the outcome definition was most variable (complications and reinterventions) between studies, whereas more concrete outcomes, such as death and graft thrombosis, displayed little heterogeneity between studies. In light of this heterogeneity, the results of the pooled analysis should be interpreted with some caution. Ideally we would have analyzed the effect of gender separately for patients with claudication or CLI and for those patients undergoing infrainguinal or aortoiliac procedures. Unfortunately, the studies tended to mix these patient populations, which made selecting out these subgroups difficult. There was also evidence of publication bias, particularly with regards to the increased risk of graft thrombosis seen in women. This may have falsely inflated the difference between men and women.
Although most of the studies in this pooled analysis showed worse outcomes in women or at least equivocal results between the sexes, it should also be noted that some of the studies included in this review actually reported improved outcomes in women. In a large population-based Danish study, men were found to be at higher risk of death and cardiovascular complications after peripheral vascular surgery, possibly due to higher rates of smoking among men. 9 Similarly, Tye et al, 52 identified better patency rates in women in a population of patients undergoing endovascular therapy for infrainguinal disease, although men had more challenging anatomy. Gallagher et al 37 also found better patency rates among women after endovascular therapy. Despite the findings of this review, the exact effect of gender on outcomes after revascularization remains a complex issue. Future studies should focus on elucidating the potential mechanisms behind any differences between the sexes by focusing on analyzing specific indications, anatomic factors (location of disease, vessel size, run-off scores), and medical optimization during revascularization.
CONCLUSIONS
Our systemic review and meta-analysis found women are at increased risk of 30-day mortality, 30-day amputations, early graft thrombosis, embolization, vascular access site complications, cardiac events, strokes, and pulmonary complications after vascular interventions compared with men. By contrast, women have similar long-term survival, graft patency, and limb salvage. The results of this meta-analysis suggest that vascular specialists should have higher thresholds when considering intervening on women with symptomatic peripheral vascular disease. It also suggests that women who undergo intervention represent a high-risk group for graft-related and systemic complications and warrant heightened follow-up, aggressive surveillance, and intensive antiatherosclerotic medical therapy. Despite these findings, there remain inconsistencies in the literature, and further prospective studies with strict methodology are required to determine whether the differences observed in outcomes reflect true biologic/pathophysiologic differences between the sexes. 
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